Conventionally fractionated stereotactic radiotherapy (CFRT) in combination with dose-dense temozolomide (TMZ) in relapsed malignant glioma: A case report

RATIONALE: At present, there is no uniform consensus on the treatment of recurrent glioblastoma, especially the re-irradiation dose and temozolomide (TMZ) dose. The literature on the treatment of recurrent glioblastoma (GBM) by conventionally fractionated stereotactic radiotherapy (CFRT) is even rar...

Descripción completa

Detalles Bibliográficos
Autores principales: Qie, Shuai, Yuan, Lanhui, Shi, Hong-Yun, Zhang, Xi, Li, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344191/
https://www.ncbi.nlm.nih.gov/pubmed/30608405
http://dx.doi.org/10.1097/MD.0000000000013869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344191/
https://www.ncbi.nlm.nih.gov/pubmed/30608405
http://dx.doi.org/10.1097/MD.0000000000013869

Ejemplares similares